323 related articles for article (PubMed ID: 18848872)
21. Control and stability of drug release from diffusion pellets coated with the aqueous quaternary polymethacrylate dispersion Eudragit RS 30 D.
Lippold BC; Monells Pagés R
Pharmazie; 2001 Jun; 56(6):477-83. PubMed ID: 11446169
[TBL] [Abstract][Full Text] [Related]
22. Citric acid as a solid-state plasticizer for Eudragit RS PO.
Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
[TBL] [Abstract][Full Text] [Related]
23. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
Leopold CS; Eikeler D
J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
[TBL] [Abstract][Full Text] [Related]
24. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
25. Accelerated stability of sulphamethoxazole microcapsules coated with Eudragit RS 100 and Eudragit RL 100.
Basnet S; Ganesan M; Pal TK
Boll Chim Farm; 2002; 141(3):202-9. PubMed ID: 12197419
[TBL] [Abstract][Full Text] [Related]
26. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
27. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
[TBL] [Abstract][Full Text] [Related]
28. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
29. Preparation and Characterization of a Novel Aqueous Dispersion for Enteric Coating of Pantoprazole Sodium Pellets.
Han M; Yu Q; Liu X; Hu F; Yuan H
Acta Pharm; 2018 Dec; 68(4):441-455. PubMed ID: 31259710
[TBL] [Abstract][Full Text] [Related]
30. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.
Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992
[TBL] [Abstract][Full Text] [Related]
31. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
[TBL] [Abstract][Full Text] [Related]
32. Film-coated zinc sulphate tablets and the effect of humidity on tablet properties.
Gürsoy A; Akbuğa J
Pharmazie; 1986 Aug; 41(8):575-8. PubMed ID: 3786379
[TBL] [Abstract][Full Text] [Related]
33. Properties of enteric coated sodium valproate pellets.
Bruce LD; Petereit HU; Beckert T; McGinity JW
Int J Pharm; 2003 Oct; 264(1-2):85-96. PubMed ID: 12972338
[TBL] [Abstract][Full Text] [Related]
34. Dry elixir formulations of dexibuprofen for controlled release and enhanced oral bioavailability.
Kim SR; Kim JK; Park JS; Kim CK
Int J Pharm; 2011 Feb; 404(1-2):301-7. PubMed ID: 21093566
[TBL] [Abstract][Full Text] [Related]
35. Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.
Wu C; McGinity JW
AAPS PharmSciTech; 2001 Nov; 2(4):24. PubMed ID: 14727861
[TBL] [Abstract][Full Text] [Related]
36. The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets.
Bruce LD; Koleng JJ; McGinity JW
Drug Dev Ind Pharm; 2003 Sep; 29(8):909-24. PubMed ID: 14570312
[TBL] [Abstract][Full Text] [Related]
37. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
38. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis.
Patel NV; Patel JK; Shah SH; Patel JN
Pharmazie; 2011 Feb; 66(2):124-9. PubMed ID: 21434575
[TBL] [Abstract][Full Text] [Related]
39. Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets.
Rujivipat S; Bodmeier R
Eur J Pharm Biopharm; 2012 May; 81(1):223-9. PubMed ID: 22269937
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.
Azarmi S; Ghaffari F; Löbenberg R; Nokhodchi A
Farmaco; 2005; 60(11-12):925-30. PubMed ID: 16223498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
